Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Enveric Biosciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 488.5K | 505.8K | +17.3K (+3.5%) |
| Value | $488.4K | $307.3K | −$181.1K (−37.1%) |
New holders (4)
Institutions that held Enveric Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 15,240 | $9.54K | 0.00% |
| FMR LLC | 120 | $74 | 0.00% |
| Mather Group, LLC. | 8 | $8 | 0.00% |
| ORG Partners LLC | 10 | $5 | 0.00% |
Sold out (5)
Institutions that held Enveric Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 40,104 | $40.1K |
| Susquehanna International Group, LLP | 18,247 | $18.2K |
| Two Sigma Investments, LP | 15,397 | $15.4K |
| Morgan Stanley | 1 | $1 |
| Acadian Asset Management LLC | 259 | $0 |